作者: Wei Hua , Hector S. Izurieta , Barbara Slade , Ermias D. Belay , Penina Haber
DOI: 10.1097/INF.0B013E3181A66471
关键词: Kawasaki disease 、 Rotavirus vaccine 、 Clinical trial 、 Vaccination 、 Placebo 、 Adverse Event Reporting System 、 Immunology 、 Adverse effect 、 Medicine 、 Vasculitis 、 Pediatrics
摘要: Background:Kawasaki disease (KD) is a multisystemic vasculitis primarily affecting children <5 years. A review of RotaTeq (rotavirus vaccine live) clinical trial data revealed higher, though not statistically significantly, KD rates among vaccines than placebo recipients. In June 2007, the R